Skip to main content
. 2013 Aug 28;209(3):420–425. doi: 10.1093/infdis/jit471

Table 1.

Unadjusted Hazard Ratios (HRs) for the Development of Fluoroquinolone (FQ)–Resistant Escherichia coli Colonization, by Baseline and Time-Varying Characteristics

Variable Value (n = 57) HR (95% CI) P
Age, y, mean ± SD 76.6 ± 12.3 1.02 (.99–1.04) .16
Female sex 15 (26.3) 1.43 (.79–2.60) .24
Nonwhite race 29 (50.9) 1.14 (.67–1.95) .63
Site
 LTCF 1 20 (35.1) Reference
 LTCF 2 33 (57.9) 0.86 (.49–1.50) .59
 LTCF 3 4 (7.0) 0.68 (.23–2.00) .48
Hospitalization in past year 43 (75.4) 1.22 (.66–2.24) .52
Comorbidity or medicationa
 Severe cardiovascular disease 10 (17.8) 1.57 (.78–3.14) .21
 Fecal incontinence 27 (47.4) 1.80 (1.06–3.04) .03
 FQ receipt in past 30 d 1 (1.8) 2.32 (.31–17.3) .41
Time-varying characteristic after enrollment
 Amoxicillin-clavulanateb 9 (15.6) 7.63 (1.75–33.3) .007
 Any antibiotic 25 (43.9) 0.63 (.15–2.64) .53
 Bed-bound status 1 (1.8) 2.02 (.49–8.43) .33
 Wheelchair dependent 24 (42.9) 1.46 (.85–2.51) .17
 Urinary catheter 6 (10.5) 3.03 (.89–10.3) .08

Data are presented as no. (%) of patients who developed FQ-resistant E. coli colonization, unless otherwise indicated.

Abbreviations: CI, confidence interval; LTCF, long-term care facility.

a Only baseline characteristics with P < .30, except FQ use, are shown.

b All other antibiotics had a P value of > .30.